{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:57:22Z","timestamp":1773277042560,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ajoc.2025.102307","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T14:52:15Z","timestamp":1743087135000},"page":"102307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment"],"prefix":"10.1016","volume":"38","author":[{"given":"Raz","family":"Tshuva-Bitton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7128-3288","authenticated-orcid":false,"given":"Michael","family":"Ostrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9203-8097","authenticated-orcid":false,"given":"Vicktoria","family":"Vishnevskia-Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Agmon-Levin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0859-6606","authenticated-orcid":false,"given":"Ifat","family":"Sher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ygal","family":"Rotenstreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ajoc.2025.102307_bib1","first-page":"477","article-title":"\u201cOn\u201d response defect in paraneoplastic night blindness with cutaneous malignant melanoma","volume":"33","author":"Alexander","year":"1992","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102307_bib2","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1523\/JNEUROSCI.6007-10.2011","article-title":"Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells","volume":"31","author":"Dhingra","year":"2011","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102307_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00041327-200109000-00004","article-title":"Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases","volume":"21","author":"Keltner","year":"2001","journal-title":"J Neuro Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102307_bib4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10633-011-9272-3","article-title":"Melanoma-associated retinopathy associated with intranasal melanoma","volume":"122","author":"Machida","year":"2011","journal-title":"Doc Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102307_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10633-020-09795-8","article-title":"Melanoma-associated retinopathy during pembrolizumab treatment probably controlled by intravitreal injections of dexamethasone","volume":"142","author":"Poujade","year":"2021","journal-title":"Doc Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102307_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10633-022-09872-0","article-title":"ISCEV Standard for full-field clinical electroretinography (2022 update)","volume":"144","author":"Robson","year":"2022","journal-title":"Doc Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajoc.2025.102307_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/tvst.9.8.10","article-title":"Chromatic pupilloperimetry measures correlate with visual acuity and visual field defects in retinitis pigmentosa patients","volume":"9","author":"Sher","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102307_bib8","first-page":"97","article-title":"Normal values of standard full field electroretinography in an Iranian population","volume":"4","author":"Parvaresh","year":"2009","journal-title":"J Ophthalmic Vis Res"},{"issue":"9","key":"10.1016\/j.ajoc.2025.102307_bib9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00262-021-02875-x","article-title":"Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma","volume":"70","author":"Khaddour","year":"2021","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102307_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2021-000889","article-title":"Autoimmune retinopathy with associated anti-retinal antibodies as a potential immune-related adverse event associated with immunotherapy in patients with advanced cutaneous melanoma: case series and systematic review","volume":"7","author":"Heng","year":"2022","journal-title":"BMJ Open Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2025.102307_bib11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1001\/jamaophthalmol.2016.2944","article-title":"Chorioretinal lesions in a case of melanoma-associated retinopathy treated with pembrolizumab","volume":"134","author":"Roberts","year":"2016","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102307_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353408","article-title":"Melanoma-associated retinopathy treated with Ipilimumab therapy","volume":"227","author":"Audemard","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.ajoc.2025.102307_bib13","article-title":"Anti-TRPM1 autoantibody-positive unilateral melanoma associated retinopathy (MAR) triggered by immunotherapy recapitulates functional and structural details of TRPM1-associated congenital stationary night blindness","volume":"36","author":"Cohen","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102307_bib14","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1078155219872786","article-title":"The impact of corticosteroid use during anti-PD1 treatment","volume":"26","author":"Pan","year":"2020","journal-title":"J Oncol Pharm Pract"},{"issue":"11","key":"10.1016\/j.ajoc.2025.102307_bib15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/archopht.1992.01080230071024","article-title":"Standardized full-field electroretinography","volume":"110","author":"Birch","year":"1992","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362500060X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245199362500060X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:27:08Z","timestamp":1760146028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245199362500060X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":15,"alternative-id":["S245199362500060X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102307","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A seven-year electroretinography follow-up of a patient with melanoma-associated retinopathy stabilized on pembrolizumab treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102307","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102307"}}